20240729_INAF_Ringkasan Risalah//Risalah RUPS_31688373_lamp2.pdf

“BEI” (https://idx.co.id) and the Company's website (https://www.indofarma.id), on 20 May 2024,
which was then corrected on 04 June 2024 regarding Changes to the Meeting Schedule.

SUMMONS to the Company's Shareholders to attend the Meeting have been made by placing
advertisements on eASY.KSEI website (https://www.akses.ksei.co.id), BEI website (https://idx.co.id)
and Company website (https://www.indofarma.id), on 03 July 2024.

The Company also uploaded Meeting Agenda Materials on the Company's website
(https://www.indofarma.id) on 03 July 2024.

There are no additional proposals for Meeting Agenda from the Company's Shareholders until the
deadline as specified in Article 23 paragraph (6) letter a of the Company's Articles of Association, namely
up to 7 days before the date of the Summons of the Meeting which was announced on July 3, 2024.

. The meeting was held with agenda items in accordance with the Meeting Invitation, as follows:

1. Approval of the Company's Annual Report and Ratification of the Company Consolidated Financial
Statement, Approval of the Report on the Supervisory Duties of the Board of Commissioners for the
2023 financial year, including ratification of the restatement of the Company Consolidated Financial
Statement forthe 2021and 2022 Financial Year and Ratification the report on the Micro and Small
Business Funding Program (PUMK) for the 2023 Financial Year, as well as granting settlement and
discharge of responsibilities fully (volledig acguit et de charge) to the Board of Directors for the
management actions of the Company and the Board of Commissioners for the Company's
supervisory actions that have been carried out during the 2023 Financial Year.

2. Approval of the Use of the Company's Net Profit for the 2023 Financial Year.

3. Determination of Remuneration (Salary/Honorarium, Facilities, and Allowances) for the 2024
Financial Year and Performance Incentives for the 2023 Financial Year for the Board of Directors
and Board of Commissioners of the Company.

4. Appointment of Public Accounting Firm (KAP) to audit the Company's Consolidated Financial
Statements and the Financial Statements for the Micro and Small Business Funding Program
(PUMK) for the 2024 Financial Year.

5. Changes in the Composition of the Company's Management.

The meeting was chaired by the Company's President Commissioner, Mr. Laksono Trisnantoro based on
the Board of Commissioners' letter Number S-20/DK-INAF/VII/2024, dated 11 July 2024.

During the Meeting, an explanation of the general condition of the Company was delivered by the
President Commissioner of the Company as Chairman of the Meeting.

. The meeting was attended by all members of the Company's Board of Commissioners and Directors as
follows:

Board of Commissioners:

President Commissioner : Laksono Trisnantoro
Commissioner : Didi Agus Mintadi
Independent Commissioner : Teddy Wibisana

Board of Directors:
President Director : Yeliandriani
Director of Operational : Andi Prazos

also Shareholders and proxy representatives of Shareholders both physically and electronically present
via eASY.KSEI, all of whom own 425,980,005 shares or 13.74453824 of the total number of shares with
valid voting rights that have been issued by the Company until the day of the Meeting is held, total of
3,099,267,500 shares consisting of:

- 1 Series A Dwiwarna share: And

-  3,099,267,499 Series B shares

taking into account the Company's Register of Shareholders as of 02 July 2024 until 16.00
West Indonesia Time.

. At the Meeting, Series A Dwiwarna Shareholders and PT Bio Farma (Persero) as the majority
Shareholders and/or their proxies were not present either physically or electronically via eASY.KSEI,
s0 the number of Shareholders and/or their proxies present was as stated in letter G above does not
meet the attendance guorum as regulated in Article 25 paragraph (1) and paragraph (4) letter a of the
Company's Articles of Association. Therefore, the Meeting cannot be held and cannot take legal and
binding decisions for all Meeting Agenda items.

In connection with the guorum for the Meeting Agenda not being met, the Chairman of the Meeting

stated that the entire Meeting Agenda will be discussed at the Second Meeting which will be held based

on the provisions of Article 23 paragraph (8) of the Company's Articles of Association which is related

to Article 20 paragraph (1) letter a and b POJK 15/2020 in conjunction with Article 25 paragraph (1)

letter b and Article 25 paragraph (4) letter b of the Company's Articles of Association. That the Company

will:

- Publish the Summons to the Second Meeting no later than 7 (seven) days before the Second
Meeting is held: and

- Hold a Second Meeting within a period of no sooner than 10 (ten) days and no later than 21 (twenty
one) days from the date of this Meeting.

The meeting was closed by the Chairman of the Meeting, Mr.Laksono Trisnantoro as President

Commissioner of the Company at 14.20 WIB.

Jakarta, 29 July 2024
Board of Directors of the Company